NDC 70436-025 – Bivalirudin

Bivalirudin 250 mg/1 · Injection, Powder, Lyophilized, For Suspension · Intravenous

Human Prescription Drug

Product NDC70436-025

Product details

Brand name
Bivalirudin
Generic name
Bivalirudin
Labeler
Slate Run Pharmaceuticals, LLC
Dosage form
Injection, Powder, Lyophilized, For Suspension
Route
Intravenous
Marketing category
ANDA · ANDA213078
Marketed since
June 30, 2021
Listing expires
December 31, 2026
Pharmacologic class
Anti-coagulant; Direct Thrombin Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Bivalirudin →

Package NDC codes (2)

Package NDCDescriptionSince
70436-025-801 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 VIAL, SINGLE-DOSE (70436-025-80)Jun 30, 2021
70436-025-8210 INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in 1 CARTON (70436-025-82)Jun 30, 2021

Other Bivalirudin products